Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus.
about
Prognostic significance of volume-based PET parameters in cancer patients.Fiducial markers coupled with 3D PET/CT offer more accurate radiation treatment delivery for locally advanced esophageal cancer.18F-deoxyglucose positron emission tomography/computed tomography to predict local failure in esophageal squamous cell carcinoma.Positron Emission Tomography (PET) in OncologyDetermination of an optimal standardized uptake value of fluorodeoxyglucose for positron emission tomography imaging to assess pathological volumes of cervical cancer: a prospective studyGradient-based delineation of the primary GTV on FLT PET in squamous cell cancer of the thoracic esophagus and impact on radiotherapy planning.Baseline ¹⁸F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancerPositron emission tomography imaging approaches for external beam radiation therapies: current status and future developmentsEstimate of the impact of FDG-avidity on the dose required for head and neck radiotherapy local controlImproved longitudinal length accuracy of gross tumor volume delineation with diffusion weighted magnetic resonance imaging for esophageal squamous cell carcinoma.Uncertainties in target volume delineation in radiotherapy - are they relevant and what can we do about them?Radiation field size and dose determine oncologic outcome in esophageal cancer.Application of metabolic PET imaging in radiation oncology.Effect of different segmentation algorithms on metabolic tumor volume measured on 18F-FDG PET/CT of cervical primary squamous cell carcinomaPET/CT planning during chemoradiotherapy for esophageal cancer.The impact of intratumoral metabolic heterogeneity on postoperative recurrence and survival in resectable esophageal squamous cell carcinoma.Use of FDG-PET in Radiation Treatment Planning for Thoracic Cancers.The application of functional imaging techniques to personalise chemoradiotherapy in upper gastrointestinal malignancies.A Dirichlet process mixture model for automatic (18)F-FDG PET image segmentation: Validation study on phantoms and on lung and esophageal lesions.A comparative study of target volumes based on 18F-FDG PET-CT and ten phases of 4DCT for primary thoracic squamous esophageal cancer.Simultaneous modulated accelerated radiation therapy for esophageal cancer: a feasibility study.The clinical application of 4D 18F-FDG PET/CT on gross tumor volume delineation for radiotherapy planning in esophageal squamous cell cancer.Relationship between (18)F-fluorodeoxyglucose uptake in primary lesions and clinicopathological characteristics of esophageal squamous cell carcinoma patients.Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability: PET/CT improves esPrognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours.Does pre-operative estimation of oesophageal tumour metabolic length using 18F-fluorodeoxyglucose PET/CT images compare with surgical pathology length?Accurate FDG PET tumor segmentation using the peritumoral halo layer method: a study in patients with esophageal squamous cell carcinoma
P2860
Q27687836-59A831F1-30C7-4874-BE1E-B74818E0E3C5Q33746586-56A8A037-73D3-496D-94E2-1395B2657027Q33798433-CCA6A7E6-10C8-4298-B6CA-5D1F01CF4B5BQ34774840-2B2648E8-F98A-41B4-AB4A-CA594A93FB3DQ35050244-1BBBFFB0-AE9B-49CF-8509-5F87C5C09AE7Q35092030-3E51F092-64C4-4945-99F4-C47CE9F44BE7Q36032993-24937E2A-92CA-497A-B187-8AA702456815Q36325435-83F39DBE-D8CB-4E9E-864C-47FE00995FC5Q36770099-93976501-780F-4F2B-8A54-6F9BF50621E7Q37046253-720897BC-52DB-4AB3-B137-9F34E0B01872Q37258706-9507191F-0B19-4B09-85BE-F1D24B55F016Q37340815-C24B9292-A4FE-46F9-A18B-0C8DC1F1E13AQ37580845-5F9A7724-208F-4B7C-B15E-7AB0494C0241Q37653213-78D62581-803B-4614-AC51-4316E1DBF8A8Q37687303-83A59090-EB31-411A-AD2D-9A16AAEF7372Q37716473-BB395CC7-7C8C-4EED-8541-BBAD5C35F923Q38016163-FDF675AD-639C-4010-91FE-555F4C7A2F78Q38226697-ECC0D13E-01E3-4E0D-A60F-1B46B2539E09Q39793373-80174AC9-38C6-45D6-882D-6FC846F7526DQ41457912-4745146C-0F96-4F40-B4E9-4A7288240D98Q41768209-5F65EC59-0F83-46C3-A8A5-39D51A812324Q42174594-04FB62C4-37AC-40FD-B2EB-E46E636D0ADDQ42414421-D59F433B-C4B7-4DEB-AA09-037DC05D0558Q43180457-44A2A465-576E-4059-B38E-AF868EC33176Q43261940-55A7542B-C39C-4366-8EB7-634F45A1C2D3Q49147470-9A59F427-4416-4326-939A-9303C7D5C69BQ53255081-651C822F-40F7-4888-B29B-35D96B52D029Q58694947-3D552535-BC31-45FA-B677-646E0ADF969A
P2860
Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Using 18F-fluorodeoxyglucose p ...... ll carcinoma of the esophagus.
@en
Using 18F-fluorodeoxyglucose p ...... ll carcinoma of the esophagus.
@nl
type
label
Using 18F-fluorodeoxyglucose p ...... ll carcinoma of the esophagus.
@en
Using 18F-fluorodeoxyglucose p ...... ll carcinoma of the esophagus.
@nl
prefLabel
Using 18F-fluorodeoxyglucose p ...... ll carcinoma of the esophagus.
@en
Using 18F-fluorodeoxyglucose p ...... ll carcinoma of the esophagus.
@nl
P2093
P1476
Using 18F-fluorodeoxyglucose p ...... ll carcinoma of the esophagus.
@en
P2093
Baijiang Zhang
Daotang Li
Dianbin Mu
Feng-Ming Kong
Guoren Yang
Jinming Yu
Pingping Song
Weidi Zhang
P304
P356
10.1016/J.IJROBP.2008.04.015
P407
P577
2008-06-04T00:00:00Z